MedDataX Logo

Length of Hospital Stay in Laparoscopic Transabdominal Preperitoneal Vs. Open Mesh Repair in Inguinal Hernia: A Randomised Controlled Trial

NCT ID: NCT05159232

Last Updated: 2021-12-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

334 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-01

Study Completion Date

2020-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare the mean length of hospital stay in laparoscopic trans abdominal preperitoneal repair versus open mesh repair in patients undergoing inguinal hernia repair with mesh.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A total of 334 patients of male gender with Inguinal hernias of any side and ASA score I and II were included in the study. History of Immunosuppression, associated with other abdominal hernias and recurrent hernia were excluded. 167 patients were in Group A or laparoscopic trans abdominal preperitoneal repair group while 167 patients were in Group B or open mesh repair. Data regarding length of hospital stay from both groups was recorded by researcher himself on especially designed proforma.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inguinal Hernia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

non-probability consecutive sampling
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

laparoscopic trans abdominal preperitoneal repair

length of hospital stay

Group Type ACTIVE_COMPARATOR

hospital stay

Intervention Type PROCEDURE

hospital stay in in inguinal hernia repair

open mesh repair of inguinal hernia

length of hospital stay

Group Type ACTIVE_COMPARATOR

hospital stay

Intervention Type PROCEDURE

hospital stay in in inguinal hernia repair

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

hospital stay

hospital stay in in inguinal hernia repair

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Age 18-60 years

* Inguinal hernias of any side as per operational definition
* ASA score I and II

Exclusion Criteria

* • H/o Immunosuppression

* Associated with other abdominal hernias
* H/o recurrent hernia
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Khyber Teaching Hospital

OTHER

Sponsor Role collaborator

Memon Medical Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

salma khan

Assistant Prof Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Salma khan, FCPS

Role: PRINCIPAL_INVESTIGATOR

rehman Medical Institute hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Khyber Teaching Hospital

Peshawar, KPK, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IREB#194-SUR-2018

Identifier Type: -

Identifier Source: org_study_id